These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

613 related articles for article (PubMed ID: 28500739)

  • 1. Feasibility and safety of transfemoral sheathless portico aortic valve implantation: Preliminary results in a single center experience.
    Taramasso M; Denegri A; Kuwata S; Rickli H; Haager PK; Sütsch G; Rodriguez Cetina Biefer H; Kottwitz J; Nietlispach F; Maisano F
    Catheter Cardiovasc Interv; 2018 Feb; 91(3):533-539. PubMed ID: 28500739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A feasibility study of transaxillary TAVI with the lotus valve.
    Doshi SN; George S; Kwok CS; Mechery A; Mamas M; Ludman PF; Townend JN; Bhabra M
    Catheter Cardiovasc Interv; 2018 Sep; 92(3):542-549. PubMed ID: 29130619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single suture-mediated closure system after transfemoral transcatheter aortic valve implantation: A single-center real-world experience.
    Iacovelli F; Burattini O; Sturdà F; Branca M; Stabile E; Fimiani L; Salemme L; Cioppa A; Pucciarelli A; Cafaro A; Bortone AS; Contegiacomo G; Pignatelli A; Tesorio T
    Catheter Cardiovasc Interv; 2024 Jun; 103(7):1125-1137. PubMed ID: 38639140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct percutaneous transaxillary implantation of a novel self-expandable transcatheter heart valve for aortic stenosis.
    Deuschl F; Schofer N; Seiffert M; Hakmi S; Mizote I; Schaefer A; Schirmer J; Reichenspurner H; Blankenberg S; Conradi L; Schäfer U
    Catheter Cardiovasc Interv; 2017 Dec; 90(7):1167-1174. PubMed ID: 28296065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of outcomes with surgical cut-down versus percutaneous transfemoral transcatheter aortic valve replacement: TAVR transfemoral access comparisons between surgical cut-down and percutaneous approach.
    Drafts BC; Choi CH; Sangal K; Cammarata MW; Applegate RJ; Gandhi SK; Kincaid EH; Kon N; Zhao DX
    Catheter Cardiovasc Interv; 2018 Jun; 91(7):1354-1362. PubMed ID: 29024382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implantation and 30-Day Follow-Up on All 4 Valve Sizes Within the Portico Transcatheter Aortic Bioprosthetic Family.
    Möllmann H; Linke A; Holzhey DM; Walther T; Manoharan G; Schäfer U; Heinz-Kuck K; Van Boven AJ; Redwood SR; Kovac J; Butter C; Søndergaard L; Lauten A; Schymik G; Worthley SG
    JACC Cardiovasc Interv; 2017 Aug; 10(15):1538-1547. PubMed ID: 28797431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transfemoral aortic valve implantation is more successful with the Edwards Sapien 3 compared with the Edwards XT for the treatment of symptomatic severe aortic stenosis.
    Gonska B; Seeger J; Junker A; Rodewald C; Trepte U; Scharnbeck D; Rottbauer W; Wöhrle J
    Arch Cardiovasc Dis; 2018; 111(8-9):470-479. PubMed ID: 29128473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complications after Transfemoral Transcatheter Aortic Valve Replacement with a Balloon-Expandable Prosthesis: The Importance of Preventative Measures and Contingency Planning.
    Chakravarty T; Jilaihawi H; Doctor N; Fontana G; Forrester JS; Cheng W; Makkar R
    Catheter Cardiovasc Interv; 2018 Apr; 91(5):E29-E42. PubMed ID: 23436313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transfemoral-only transcatheter aortic valve replacement: A single center experience of 400 consecutive patients.
    Moccetti F; Wolfrum M; Bossard M; Attinger-Toller A; Loretz L; Cuculi F; Toggweiler S
    Catheter Cardiovasc Interv; 2024 Jul; 104(1):134-144. PubMed ID: 38736247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unilateral Access Is Safe and Facilitates Peripheral Bailout During Transfemoral-Approach Transcatheter Aortic Valve Replacement.
    Khubber S; Bazarbashi N; Mohananey D; Kadri A; Gad MM; Kaur M; Sammour YM; Lyden M; Ahuja KR; Verma B; Menon V; Mick SL; Reed GW; Puri R; Svensson L; Navia JL; Tuzcu EM; Krishnaswamy A; Kapadia SR
    JACC Cardiovasc Interv; 2019 Nov; 12(21):2210-2220. PubMed ID: 31699379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A less-invasive totally-endovascular (LITE) technique for trans-femoral transcatheter aortic valve replacement.
    Burzotta F; Aurigemma C; Romagnoli E; Shoeib O; Russo G; Zambrano A; Verdirosi D; Leone AM; Bruno P; Trani C
    Catheter Cardiovasc Interv; 2020 Aug; 96(2):459-470. PubMed ID: 31925991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Procedural and thirty-day outcomes following transfemoral implantation of the fully repositionable and retrievable Lotus valve without routine pre-dilatation in a consecutive patient cohort: a single-center experience.
    Ruparelia N; Thomas K; Newton JD; Grebenik K; Keiralla A; Krasopoulos G; Sayeed R; Banning AP; Kharbanda RK
    Cardiovasc Revasc Med; 2018; 19(1 Pt B):78-82. PubMed ID: 29137967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative data of single versus double proglide vascular preclose technique after percutaneous transfemoral transcatheter aortic valve implantation from the optimized catheter valvular intervention (OCEAN-TAVI) japanese multicenter registry.
    Kodama A; Yamamoto M; Shimura T; Kagase A; Koyama Y; Tada N; Takagi K; Araki M; Yamanaka F; Shirai S; Watanabe Y; Hayashida K
    Catheter Cardiovasc Interv; 2017 Sep; 90(3):E55-E62. PubMed ID: 27785881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Safety and feasibility of sheathless transfemoral aortic valve implantation].
    Pei HJ; Teng SY; Luo T; Wu YJ; Yang YJ; Qiao SB; Xu B; Gao RL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Sep; 45(9):782-785. PubMed ID: 29036977
    [No Abstract]   [Full Text] [Related]  

  • 15. Transfemoral aortic valve implantation with new-generation devices: the repositionable Lotus vs. the balloon-expandable Edwards Sapien 3 valve.
    Nai Fovino L; Badawy MRA; Fraccaro C; D'Onofrio A; Purita PAM; Frigo AC; Tellaroli P; Mauro A; Tusa M; Napodano M; Gerosa G; Iliceto S; Bedogni F; AbdelRheim AER; Tarantini G
    J Cardiovasc Med (Hagerstown); 2018 Nov; 19(11):655-663. PubMed ID: 30299408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictability and Outcome of Vascular Complications after Transfemoral Transcatheter Aortic Valve Implantation.
    Uguz E; Gokcimen M; Ali S; Alsancak Y; Bastug S; Ahmet Kasapkara H; Canyigit M; Hıdıroglu M; Sener E
    J Heart Valve Dis; 2016 Mar; 25(2):173-181. PubMed ID: 27989061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcutaneous aortic valve implantation using the carotid artery access: Feasibility and clinical outcomes.
    Kallinikou Z; Berger A; Ruchat P; Khatchatourov G; Fleisch I; Korkodelovic B; Henchoz E; Marti RA; Cook S; Togni M; Goy JJ
    Arch Cardiovasc Dis; 2017; 110(6-7):389-394. PubMed ID: 28433509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of suture mediated femoral access site closure with the Prostar XL compared to the ProGlide system on outcome in transfemoral aortic valve implantation.
    Seeger J; Gonska B; Rodewald C; Rottbauer W; Wöhrle J
    Int J Cardiol; 2016 Nov; 223():564-567. PubMed ID: 27561160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Procedural and 30-day clinical outcomes following transcatheter aortic valve replacement with lotus valve: Results of the RELEVANT study.
    Montone RA; Testa L; Fraccaro C; Montorfano M; Castriota F; Nerla R; Angelillis M; Tusa M; Giannini F; Garatti A; Tarantini G; Petronio AS; Brambilla N; Bedogni F
    Catheter Cardiovasc Interv; 2017 Dec; 90(7):1206-1211. PubMed ID: 28145039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis of transfemoral TAVR versus surgical aortic valve replacement.
    Arora S; Vaidya SR; Strassle PD; Misenheimer JA; Rhodes JA; Ramm CJ; Wheeler EN; Caranasos TG; Cavender MA; Vavalle JP
    Catheter Cardiovasc Interv; 2018 Mar; 91(4):806-812. PubMed ID: 29068166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.